Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Survey reveals low awareness of postherpetic neuralgia amongst Americans

Survey reveals low awareness of postherpetic neuralgia amongst Americans

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Endo Pharmaceuticals signs agreement to acquire HealthTronics

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

Depomed attributes 56% increase in first-quarter revenue to $5.8M increase in Glumetza product sales

Depomed attributes 56% increase in first-quarter revenue to $5.8M increase in Glumetza product sales

Adolor's ENTEREG first-quarter net product sales increases to $5.3 million

Adolor's ENTEREG first-quarter net product sales increases to $5.3 million

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

PRTT completes acquisition of multiple patents and patents-pending from Nectid

PRTT completes acquisition of multiple patents and patents-pending from Nectid

Physician panel to discuss issues related to Qutenza at Investor Day

Physician panel to discuss issues related to Qutenza at Investor Day

XenoPort to present arbaclofen placarbil, XP13512 trial data at 62nd American Academy of Neurology meeting

XenoPort to present arbaclofen placarbil, XP13512 trial data at 62nd American Academy of Neurology meeting

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Qutenza 8% patch now available for pain associated with PHN: NeurogesX

Qutenza 8% patch now available for pain associated with PHN: NeurogesX

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

Depomed licensee submits DM-1796 NDA for management of PHN

Depomed licensee submits DM-1796 NDA for management of PHN

Nutra Pharma's Cobroxin pain reliever now available at CVS stores

Nutra Pharma's Cobroxin pain reliever now available at CVS stores

Inflamed tissues linked to increased production of protein involved in pain signaling

Inflamed tissues linked to increased production of protein involved in pain signaling